Cornerstone Capital Resources
CVE:CGPCornerstone Capital Resources Inc., through its subsidiaries, engages in the acquisition, evaluation, and exploration of mineral properties in Ecuador and Chile. The company primarily explores for gold, copper, and silver deposits. Its flagship project is the Cascabel project located in northern Ecuador. The company was founded in 1997 and is based in Ottawa, Canada.
Hospira
NYSE:HSPHospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
North American Palladium
TSE:PDLNorth American Palladium Ltd. produces precious metals in Canada. It explores for palladium, platinum, gold, nickel, copper, and other metals. It primarily holds interest in the Lac des Iles mine that is located to the northwest of Thunder Bay, Ontario. The company was founded in 1968 and is headquartered in Toronto, Canada.